Form 424B5 Traws Pharma, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Traws Pharma increases ATM offering capacity by $3.1 million
May 22, 2026 8:04 AM EDTTraws Pharma (NASDAQ: TRAW) filed a prospectus supplement to increase its at-the-market offering capacity by $3,128,399, according to a Securities and Exchange Commission filing.
The biopharmaceutical company previously sold 3,607,270 shares under its existing ATM agreement with Citizens JMP Securities for gross proceeds of... More
